Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment

23 Apr 2021

Abstract excerpt

Female breast cancer (BCa) is the most commonly occurring cancer worldwide. The tumor microenvironment (TME) plays an essential role in tumor invasion, angiogenesis, unlimited proliferation, and even immune escape, but we know little about the TME of BCa. In this study, we aimed to find a TME-related biomarker for BCa, especially for invasive breast carcinoma (BRCA), that could predict prognosis and immunotherapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33968066
DOI: 10.3389/fimmu.2021.664845

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentPMID 33968066Read ↗

A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based StudySemantic proximity Read ↗

CD1C is associated with Breast Cancer Prognosis and Immune InfiltratesSemantic proximity Read ↗

Comprehensive Analysis of the Immune Microenvironment Reveals that CD52 is a Marker for Breast Cancer Treatment with Immune Checkpoint InhibitorsSemantic proximity Read ↗

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA databaseSemantic proximity Read ↗

Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.Semantic proximity Read ↗

Immune-related Gene Data-based Molecular Subtyping Related to the Prognosis for Breast Cancer PatientsSemantic proximity Read ↗

Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer.Semantic proximity Read ↗

Screening of tumor microenvironment-related prognostic genes in breast cancer by data miningSemantic proximity Read ↗

Immune Microenvironment-Related Genes Contribute to Clinical Prognosis in Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancerSemantic proximity Read ↗

Identification of prognostic genes from the breast cancer microenvironmentSemantic proximity Read ↗

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.